Adding daratumumab to lenalidomide in maintenance therapy for multiple myeloma significantly reduced rates of minimal ...

After putting on a strong performance in preventing disease progression in the earlier treatment of multiple myeloma, Johnson ...

Johnson & Johnson linked Carvykti to a 45% reduction in risk of death and Darzalex to a 61% improvement in minimal residual ...

Legend Biotech said Friday its cancer drug, Carvykti, lowered the risk of death by 45% in a study of multiple myeloma patients.

As part of his upcoming tell-all memoir 'Unleashed' Boris Johnson recalled his final meeting with the monarch, stating he had ...

Ongoing investigation into the use of thalidomide in the treatment of multiple myeloma has demonstrated efficacy as a combination treatment during induction and as maintenance therapy. Thalidomide ...

Welcome to the Evening Wrap newsletter, your guide to the day’s biggest stories with concise analysis from The Hindu. The Congress on Sunday attacked the BJP after a case was lodged against ...